Founded in 2012, ipCreate will continue to provide industry
leaders in the US, Europe and Asia with on-demand patented inventions at the
chokepoints of disruptive market change, with the patents themselves and
related landscape opportunity systematically vetted by AOP’s global network of
prior art researchers adding to quality assurance. With poor quality
patents a growing burden on business and the subject of mounting challenges by
the courts and the U.S. Patent and Trademark Office (USPTO), the integration of
patent quality control processes early in the invention process is expected to
fill a vital customer need.
“One of the lessons my three-and-a-half years as
head of the Patent and Trademark Office taught me is that
businesses benefit greatly from a systemic approach
to improving the quality of their patents — and the
earlier in the innovation process, the better,” said David Kappos,
ipCreate advisor and former Director of the USPTO. “With this merger,
ipCreate has now put all the pieces in place to provide clients
with high-value innovation on demand backed by unusually high-quality
intellectual property.”
. . .
John Cronin, CEO of ipCreate, was also instrumental in the
merger. “When I was IBM’s top inventor and ran its ‘patent factory’ in the
1990s, some people thought it was just a numbers game — about having the most
patents. That was never what it was about,” he explained. “Our goal was to
develop high-quality patented inventions in disruptive technologies. That’s how
IBM invented the future. With Article One Partner’s help, that’s what we intend
to do again. Only now we plan to invent “on demand” to suit the specific needs
of our partners and to the highest standards of quality.”
Article One Partners brings much to the table. "The merger is expected to provide a number of strategic benefits including the ability to leverage AOP’s existing customer base, strong “white-hat” branding, enhanced patent intelligence, patent quality services and increased depth in executive leadership through the addition of Marshall Phelps and the AOP management team."
The board of directors and the advisory group is impressive, including Marshall Phelps, Jr., John Cronin, Peter Holden,
Robert Armitage, Ruud Peters, David Kappos and Mike Brochu. The leadership team is also a distinguished group.
So, the game is not so much about amassing patents, but
strategically acquiring one or a small set of quality patents (read Alice) “at the chokepoint[].” True enough, most agree that quality patents
are not so much a problem; however, litigation “abuse” is something that I am
sure others will complain about. But, I
think this group will “work around” that problem with sensible licensing
practices.
Here is a blurb about the
philosophy of ipCreate:
Our mission is to
forecast the direction of innovation in the fastest-growing new product markets
and then create strategic patent portfolios in the disruptive high-value
technologies driving that growth. We know first-hand that the greatest value in
the IP asset class belongs to a small minority of foundational patents. By
working with select leaders in industries undergoing rapid technological
disruption – whether dominant players in the market or visionary startups – we
will employ ipCreate’s proprietary tools and resources to identify promising
innovation areas and rapidly create foundational patents at the chokepoints of
looming market change.
With major
financial backing, we expect to fund and execute more than 100 strategic
invention and IP creation projects and produce thousands of foundational
patents by the year 2017. By restoring the historic link between patents and
invention (rather than litigation), ipCreate also hopes to strengthen a patent
system that is crucial to U.S. competitiveness.
I think the merger with Article One Partners is a pretty damn good idea. Who doesn't want to wear a "white hat?" I do wonder how many of the researchers will go along with the new venture. [I have to say that I also like how they put “ip” in lower case letters and
capitalize the “C” in create.] What do you think?
No comments:
Post a Comment